Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Increasing evidence suggests that bone marrow derived-mesenchymal stem cells (MSCs) have neuroprotective properties and a major mechanism of action is through their capacity to secrete a diverse range of potentially neurotrophic or anti-oxidant factors. The recent discovery that MSCs secrete superoxide dismutase 3 (SOD3) may help explain studies in which MSCs have a direct anti-oxidant activity that is conducive to neuroprotection in both in vivo and in vitro. SOD3 attenuates tissue damage and reduces inflammation and may confer neuroprotective effects against nitric oxide-mediated stress to cerebellar neurons; but, its role in relation to central nervous system inflammation and neurodegeneration has not been extensively investigated. Here we have performed a series of experiments showing that SOD3 secretion by human bone marrow-derived MSCs is regulated synergistically by the inflammatory cytokines TNF-alpha and IFN-gamma, rather than through direct exposure to reactive oxygen species. Furthermore, we have shown SOD3 secretion by MSCs is increased by activated microglial cells. We have also shown that MSCs and recombinant SOD are able to increase both neuronal and axonal survival in vitro against nitric oxide or microglial induced damage, with an increased MSC-induced neuroprotective effect evident in the presence of inflammatory cytokines TNF-alpha and IFN-gamma. We have shown MSCs are able to convey these neuroprotective effects through secretion of soluble factors alone and furthermore demonstrated that SOD3 secretion by MSCs is, at least, partially responsible for this phenomenon. SOD3 secretion by MSCs maybe of relevance to treatment strategies for inflammatory disease of the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Halliwell, B. (2006). Oxidative stress and neurodegeneration: Where are we now? Journal of Neurochemistry, 97(6), 1634–1658.

    Article  CAS  PubMed  Google Scholar 

  2. Emerit, J., Edeas, M., & Bricaire, F. (2004). Neurodegenerative diseases and oxidative stress. Biomedicine & Pharmacotherapy, 58(1), 39–46.

    Article  CAS  Google Scholar 

  3. Lin, M. T., & Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443(7113), 787–795.

    Article  CAS  PubMed  Google Scholar 

  4. Rosen, D. R. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 364(6435), 362.

    CAS  PubMed  Google Scholar 

  5. Parr, A. M., Tator, C. H., & Keating, A. (2007). Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplantation, 40(7), 609–619.

    Article  CAS  PubMed  Google Scholar 

  6. Wilkins, A., Kemp, K., Ginty, M., Hares, K., Mallam, E., & Scolding, N. (2009). Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res, 3(1), 63–70.

    Google Scholar 

  7. Arnhold, S., Klein, H., Klinz, F. J., et al. (2006). Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. European Journal of Cell Biology, 85(6), 551–565.

    Article  CAS  PubMed  Google Scholar 

  8. Hokari, M., Kuroda, S., Shichinohe, H., Yano, S., Hida, K., & Iwasaki, Y. (2008). Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. Journal of Neuroscience Research, 86(5), 1024–1035.

    Article  CAS  PubMed  Google Scholar 

  9. Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D., & Phinney, D. G. (2006). Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology, 198(1), 54–64.

    Article  CAS  PubMed  Google Scholar 

  10. Lanza, C., Morando, S., Voci, A., et al. (2009). Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. Journal of Neurochemistry, 110(5), 1674–1684.

    Article  CAS  PubMed  Google Scholar 

  11. Kemp, K., Hares, K., Mallam, E., Heesom, K. J., Scolding, N., & Wilkins, A. (2009). Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. Journal of Neurochemistry, doi:10.1111/j.1471-4159.2009.06553.x.

  12. Ratnam, D. V., Ankola, D. D., Bhardwaj, V., Sahana, D. K., & Kumar, M. N. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release, 113(3), 189–207.

    Article  CAS  PubMed  Google Scholar 

  13. Christofidou-Solomidou, M., & Muzykantov, V. R. (2006). Antioxidant strategies in respiratory medicine. Treatments in Respiratory Medicine, 5(1), 47–78.

    Article  CAS  PubMed  Google Scholar 

  14. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.

    Article  CAS  PubMed  Google Scholar 

  15. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317.

    Article  CAS  PubMed  Google Scholar 

  16. Kim, Y. J., Park, H. J., Lee, G., et al. (2009). Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia, 57(1), 13–23.

    Article  PubMed  Google Scholar 

  17. Broholm, H., Andersen, B., Wanscher, B., et al. (2004). Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurologica Scandinavica, 109(4), 261–269.

    Article  CAS  PubMed  Google Scholar 

  18. Smith, K. J., Kapoor, R., & Felts, P. A. (1999). Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathology, 9(1), 69–92.

    Article  CAS  PubMed  Google Scholar 

  19. Mohamed, A., Shoker, A., Bendjelloul, F., et al. (2003). Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomedical Sciences Instrumentation, 39, 440–445.

    CAS  PubMed  Google Scholar 

  20. Ruuls, S. R., Van Der Linden, S., Sontrop, K., Huitinga, I., & Dijkstra, C. D. (1996). Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clinical and Experimental Immunology, 103(3), 467–474.

    Article  CAS  PubMed  Google Scholar 

  21. Qi, X., Sun, L., Lewin, A. S., Hauswirth, W. W., & Guy, J. (2007). Long-term suppression of neurodegeneration in chronic experimental optic neuritis: Antioxidant gene therapy. Investig Ophthalmol Vis Sci, 48(12), 5360–5370.

    Article  Google Scholar 

  22. Nozik-Grayck, E., Suliman, H. B., & Piantadosi, C. A. (2005). Extracellular superoxide dismutase. The International Journal of Biochemistry & Cell Biology, 37(12), 2466–2471.

    Article  CAS  Google Scholar 

  23. Brown, G. C., & Borutaite, V. (2006). Interactions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species. Biochemical Society Transactions, 34(Pt 5), 953–956.

    CAS  PubMed  Google Scholar 

  24. Lob, H. E., Marvar, P. J., Guzik, T. J., et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension, 55(2), 277–283.

  25. Laurila, J. P., Laatikainen, L. E., Castellone, M. D., & Laukkanen, M. O. (2009). SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. PLoS ONE, 4(6), e5786.

    Article  PubMed  Google Scholar 

  26. Folz, R. J., Abushamaa, A. M., & Suliman, H. B. (1999). Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. Journal of Clinical Investigation, 103(7), 1055–1066.

    Article  CAS  PubMed  Google Scholar 

  27. Bowler, R. P., Nicks, M., Tran, K., et al. (2004). Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. American Journal of Respiratory Cell and Molecular Biology, 31(4), 432–439.

    Article  CAS  PubMed  Google Scholar 

  28. Gao, F., Koenitzer, J. R., Tobolewski, J. M., et al. (2008). Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. The Journal of Biological Chemistry, 283(10), 6058–6066.

    Article  CAS  PubMed  Google Scholar 

  29. Ha, H. Y., Kim, Y., Ryoo, Z. Y., & Kim, T. Y. (2006). Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Biochemical and Biophysical Research Communications, 348(2), 450–458.

    Article  CAS  PubMed  Google Scholar 

  30. Lubrano, V., Di Cecco, P., & Zucchelli, G. C. (2006). Role of superoxide dismutase in vascular inflammation and in coronary artery disease. Clinical and Experimental Medicine, 6(2), 84–88.

    Article  CAS  PubMed  Google Scholar 

  31. Rabbani, Z. N., Anscher, M. S., Folz, R. J., et al. (2005). Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer, 5(59).

  32. Ueda, J., Starr, M. E., Takahashi, H., et al. (2008). Decreased pulmonary extracellular superoxide dismutase during systemic inflammation. Free Radical Biology & Medicine, 45(6), 897–904.

    Article  CAS  Google Scholar 

  33. Marklund, S. L. (1990). Expression of extracellular superoxide dismutase by human cell lines. The Biochemical Journal, 266(1), 213–219.

    CAS  PubMed  Google Scholar 

  34. Harris, C. A., Derbin, K. S., Hunte-McDonough, B., et al. (1991). Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. Journal of Immunology, 147(1), 149–154.

    CAS  Google Scholar 

  35. Marklund, S. L. (1992). Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. The Journal of Biological Chemistry, 267(10), 6696–6701.

    CAS  PubMed  Google Scholar 

  36. Olofsson, E. M., Marklund, S. L., Pedrosa-Domellof, F., & Behndig, A. (2007). Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. Molecular Vision, 13, 1285–1290.

    CAS  PubMed  Google Scholar 

  37. Stralin, P., & Marklund, S. L. (2000). Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis, 151(2), 433–441.

    Article  CAS  PubMed  Google Scholar 

  38. Stralin, P., & Marklund, S. L. (2001). Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. American Journal of Physiology. Heart and Circulatory Physiology, 281(4), H1621–H1629.

    CAS  PubMed  Google Scholar 

  39. Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983). Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. The Journal of Experimental Medicine, 158(3), 670–689.

    Article  CAS  PubMed  Google Scholar 

  40. Berkow, R. L., Wang, D., Larrick, J. W., Dodson, R. W., & Howard, T. H. (1987). Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. Journal of Immunology, 139(11), 3783–3791.

    CAS  Google Scholar 

  41. Matsubara, T., & Ziff, M. (1986). Increased superoxide anion release from human endothelial cells in response to cytokines. Journal of Immunology, 137(10), 3295–3298.

    CAS  Google Scholar 

  42. Tiku, M. L., Liesch, J. B., & Robertson, F. M. (1990). Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. Journal of Immunology, 145(2), 690–696.

    CAS  Google Scholar 

  43. Benveniste, E. N., & Benos, D. J. (1995). TNF-alpha- and IFN-gamma-mediated signal transduction pathways: Effects on glial cell gene expression and function. The FASEB Journal, 9(15), 1577–1584.

    CAS  PubMed  Google Scholar 

  44. Shi, N., Kawano, Y., Matsuoka, T., et al. (2009). Increase of CD4 + TNF{alpha} + IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients. Multiple Sclerosis, 15(1), 120–123.

    Article  CAS  PubMed  Google Scholar 

  45. Baraczka, K., Pozsonyi, T., Szuts, I., Ormos, G., & Nekam, K. (2003). Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis. Acta Microbiologica et Immunologica Hungarica, 50(4), 339–348.

    Article  CAS  PubMed  Google Scholar 

  46. Sharief, M. K., Noori, M. A., Ciardi, M., Cirelli, A., & Thompson, E. J. (1993). Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. Journal of Neuroimmunology, 43(1–2), 15–21.

    Article  CAS  PubMed  Google Scholar 

  47. Jensen, M. B., Hegelund, I. V., Lomholt, N. D., Finsen, B., & Owens, T. (2000). IFNgamma enhances microglial reactions to hippocampal axonal degeneration. The Journal of Neuroscience, 20(10), 3612–3621.

    CAS  PubMed  Google Scholar 

  48. Renno, T., Taupin, V., Bourbonniere, L., et al. (1998). Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Molecular and Cellular Neurosciences, 12(6), 376–389.

    Article  CAS  PubMed  Google Scholar 

  49. Renno, T., Krakowski, M., Piccirillo, C., Lin, J. Y., & Owens, T. (1995). TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. Journal of Immunology, 154(2), 944–953.

    CAS  Google Scholar 

  50. Stralin, P., & Marklund, S. L. (1994). Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochemical Journal, 298(Pt 2), 347–352.

    PubMed  Google Scholar 

  51. Abrams, M. B., Dominguez, C., Pernold, K., et al. (2009). Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restorative Neurology and Neuroscience, 27(4), 307–321.

    PubMed  Google Scholar 

  52. Park, H. J., Lee, P. H., Ahn, Y. W., et al. (2007). Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. The European Journal of Neuroscience, 26(1), 79–89.

    Article  PubMed  Google Scholar 

  53. Vercelli, A., Mereuta, O. M., Garbossa, D., et al. (2008). Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 31(3), 395–405.

    Article  CAS  PubMed  Google Scholar 

  54. Chopp, M., & Li, Y. (2002). Treatment of neural injury with marrow stromal cells. Lancet Neurology, 1(2), 92–100.

    Article  PubMed  Google Scholar 

  55. Mahmood, A., Lu, D., Lu, M., & Chopp, M. (2003). Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery, 53(3), 697–702. discussion 702–3.

    Article  PubMed  Google Scholar 

  56. Mahmood, A., Lu, D., Qu, C., Goussev, A., & Chopp, M. (2005). Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery, 57(5), 1026–1031. discussion 1026–31.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was carried out using a project grant from Ataxia UK.

Disclosures

The authors indicate no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Multiple Sclerosis and Stem Cell Group, Institute of Clinical Neurosciences, Clinical Sciences North Bristol, University of Bristol, Bristol, UK

    Kevin Kemp, Elizabeth Gray, Elizabeth Mallam, Neil Scolding & Alastair Wilkins

  2. Burden Centre, Frenchay Hospital, MS labs, 1st floor, Bristol, BS16 1JB, UK

    Kevin Kemp

Authors
  1. Kevin Kemp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Mallam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neil Scolding
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alastair Wilkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin Kemp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemp, K., Gray, E., Mallam, E. et al. Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells. Stem Cell Rev and Rep 6, 548–559 (2010). https://doi.org/10.1007/s12015-010-9178-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-010-9178-6

Keywords

Search

Navigation